Michael S. Wiesener

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Diagnosing Mendelian Kidney Disease: Hidden Niches in the (Kidney) Genome.

Diagnosing Mendelian Kidney Disease: Hidden Niches in the (Kidney) Genome.

Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation

Published: December 22, 2025

Targeted VNTR long read sequencing resolves a diagnostic bottleneck in ADTKD and detects de novo ADTKD-MUC1.

Targeted VNTR long read sequencing resolves a diagnostic bottleneck in ADTKD and detects de novo ADTKD-MUC1.

Journal: Kidney international

Published: November 03, 2025

MYH9 Variant p.(Arg424Gly) Alters Nonmuscle Myosin IIA Contraction, Causing Atypical MYH9-related Disease.

MYH9 Variant p.(Arg424Gly) Alters Nonmuscle Myosin IIA Contraction, Causing Atypical MYH9-related Disease.

Journal: Kidney international reports

Published: October 24, 2025

JAG1 of all trades, master of CKD? The role of JAG1 in autosomal dominant tubulointerstitial kidney disease.

JAG1 of all trades, master of CKD? The role of JAG1 in autosomal dominant tubulointerstitial kidney disease.

Journal: Kidney international

Published: September 21, 2025

Alport Syndrome is a Partial Tubulointerstitial Disease of the Kidney.

Alport Syndrome is a Partial Tubulointerstitial Disease of the Kidney.

Journal: Kidney international reports

Published: August 29, 2025

ACTN4 p.Ile150Met Causes FSGS With Validation in Primary Fibroblasts and Immortalized Podocytes.

ACTN4 p.Ile150Met Causes FSGS With Validation in Primary Fibroblasts and Immortalized Podocytes.

Journal: Kidney international reports

Published: March 14, 2025

Preemptive Conversion to mTOR Inhibition to Prevent Primary Cytomegalovirus Infection in Kidney Transplantation with High-Risk Serostatus.

Preemptive Conversion to mTOR Inhibition to Prevent Primary Cytomegalovirus Infection in Kidney Transplantation with High-Risk Serostatus.

Journal: Transplantation proceedings

Published: November 28, 2024

Pharmacodynamic effect of mTOR inhibition-based immunosuppressive therapy on dendritic cell and natural killer cell subsets after renal transplantation.

Pharmacodynamic effect of mTOR inhibition-based immunosuppressive therapy on dendritic cell and natural killer cell subsets after renal transplantation.

Journal: Clinical and experimental immunology

Published: August 09, 2024

Progressive Kidney Failure by Angiotensinogen Inactivation in the Germline.

Progressive Kidney Failure by Angiotensinogen Inactivation in the Germline.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: July 15, 2024

Pharmacodynamic Effect of mTOR Inhibition-based Immunosuppressive Therapy on T- and B-cell Subsets After Renal Transplantation.

Pharmacodynamic Effect of mTOR Inhibition-based Immunosuppressive Therapy on T- and B-cell Subsets After Renal Transplantation.

Journal: Transplantation direct

Published: March 09, 2024

Hypoxia controls expression of kidney-pathogenic MUC1 variants.

Hypoxia controls expression of kidney-pathogenic MUC1 variants.

Journal: Life science alliance

Published: April 05, 2023

Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU study).

Excellent efficacy and beneficial safety during observational 5-year follow-up of rapid steroid withdrawal after renal transplantation (Harmony FU study).

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: February 09, 2023

Showing 1-12 of 55

Last Updated: 09/26/2026